LA CaTS Member Institutions, LSU Health Sciences Center-New Orleans and University Medical Center, are participating in one of four clinical trials from NIH’s Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Program. This particular trial will test the safety and effectiveness of monoclonal antibodies as a potential coronavirus treatment.

Click HERE to view the full article from the LSU Health New Orleans News Room site.